ArticleActa pharmacologica Sinica2018

Rapamycin inhibits ox-LDL-induced inflammation in human endothelial cells in vitro by inhibiting the mTORC2/PKC/c-Fos pathway.

Juan-Juan Sun et al.PubMed ↗Full text ↗Publisher ↗

No numbers read from the abstract.